Hudson Bay Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-199,900
Closed -$9.02M 1219
2025
Q3
$9.02M Buy
199,900
+192,900
+2,756% +$9.01M 0.03% 384
2025
Q2
$324K Buy
+7,000
New +$344K ﹤0.01% 1161
2024
Q4
Sell
-82,700
Closed -$4.28M 926
2024
Q3
$4.28M Buy
+82,700
New +$3.88M 0.02% 443
2019
Q2
Sell
-658,700
Closed -$31.4M 447
2019
Q1
$31.4M Buy
658,700
+598,700
+998% +$29.8M 0.41% 44
2018
Q4
$3.12M Buy
+60,000
New +$3.22M 0.04% 415
2018
Q1
Sell
-368,200
Closed -$22.6M 778
2017
Q4
$22.6M Sell
368,200
-652,700
-64% -$40.8M 0.48% 28
2017
Q3
$65.1M Buy
1,020,900
+270,900
+36% +$15.8M 1.62% 8
2017
Q2
$41.8M Sell
750,000
-400,000
-35% -$21.8M 0.84% 20
2017
Q1
$62.5M Buy
1,150,000
+825,000
+254% +$45.2M 0.84% 21
2016
Q4
$19M Sell
325,000
-813,700
-71% -$44.5M 0.39% 49
2016
Q3
$61.4M Buy
+1,138,700
New +$73.1M 1.48% 13

Other funds holding BMY

Hudson Bay Capital Management's BMY Position: Q4 2025 in Review

Hudson Bay Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 74,101 shares — an estimated $3.34M sold.

Hudson Bay Capital Management first reported a position in BMY in Q3 2016 and held it in 14 quarters. The position peaked at $17.6M in Q1 2017. 2,451 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Hudson Bay Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
  • Hudson Bay Capital Management sold 74,101 Bristol-Myers Squibb shares in Q4 2025, an estimated $3.34M.
  • Hudson Bay Capital Management first reported a position in Bristol-Myers Squibb in Q3 2016 and held it in 14 quarters.
  • Hudson Bay Capital Management's Bristol-Myers Squibb position peaked at $17.6M in Q1 2017.
  • 2,451 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Hudson Bay Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.